Innovation Theaters

April 23, 2021

 

9:45 AM

Selecting a First-in-Class Oral Therapy for Patients With HR+/HER2- Metastatic Breast Cancer

Speaker: Gena Volas-Redd, MD

Supported by: Pfizer

 

12:40 PM

An Individualized Approach: A CDK4 & 6 Inhibitor For Women With Reduced Survival in HR+, HER2- MBC

Speaker: Laila Agrawal, MD
 

Supported by: Lilly

April 24, 2021

 

9:45 AM


The only once-daily, oral maintenance therapy for all first-line platinum responders with advanced ovarian cancer, regardless of biomarker status

Speaker: Matt Anderson, MD, PhD

Supported by: GSK

 

12:20 PM

Maintenance Therapy in Advanced Ovarian Cancer: Results From Key Clinical Trials

Speaker: Sharyn Lewin, MD, FACS, FACOG

Supported by: AstraZeneca

 

Industry-led lectures will be conducted in conjunction with this event to provide promotional product-specific information on available agents and products in development.

The above commercial program is not a part of Great Debates & Updates in Women's Oncology. It is not organized or endorsed by Imedex.

 

*All times subject to change.